Victoza® 18mg Injection

Victoza® 18mg Injection is an injectable medicine containing liraglutide, a glucagon-like peptide-1 receptor agonist, commonly known as a GLP-1 receptor agonist. It is a prescription medicine intended for use only under the supervision of a licensed healthcare professional.

Victoza® provides an injectable liraglutide option for patients who are prescribed GLP-1 receptor agonist therapy. The 18mg pen strength is generally used according to a doctor’s treatment plan and should not be started, changed, or stopped without medical advice.

Product Information

• Product Name: Victoza® 18mg Injection
• Japanese Name: ビクトーザ皮下注18mg
• Chinese Name: Victoza® 18mg 注射液（Liraglutide）
• Active Ingredient: Liraglutide
• Strength: 18mg
• Dosage Form: Injection
• Route of Administration: Subcutaneous
• Drug Class: GLP-1 receptor agonist
• Brand Owner: Novo Nordisk
• Product Type: Prescription medicine
• Use: Use only as directed by a licensed healthcare professional

What Is Victoza® 18mg Injection?

Victoza® 18mg Injection contains liraglutide in an injectable form for subcutaneous administration. Liraglutide belongs to the GLP-1 receptor agonist class, which is associated with blood glucose regulation, insulin response, glucagon secretion, gastric emptying, and appetite-related signaling.

Victoza® is administered by injection under the skin as directed by a healthcare professional. The exact dose, injection schedule, and treatment duration should be determined by a doctor based on the patient’s medical condition, treatment response, and tolerability.

This product should not be used without medical advice, diagnosis, and prescription.

Key Features

Victoza® 18mg Injection is known for:

• Contains liraglutide 18mg
• Injectable subcutaneous format
• GLP-1 receptor agonist medicine
• Liraglutide-based injectable option
• Used according to healthcare professional treatment plan
• Manufactured by Novo Nordisk
• Prescription-only medicine
• Should be used with medical monitoring and lifestyle guidance

About Liraglutide

Liraglutide is a GLP-1 receptor agonist. GLP-1 receptor agonists work by activating GLP-1 receptors involved in metabolic regulation.

Under healthcare professional guidance, liraglutide may help support:

• Blood glucose management
• Insulin secretion response when blood glucose is elevated
• Reduced glucagon release when appropriate
• Slower gastric emptying
• Appetite and satiety-related signaling
• Overall metabolic care as part of a treatment plan

The effect and suitability of liraglutide depend on each patient’s health condition, current medications, medical history, and doctor’s assessment.

Dose Strength Information

The 18mg strength generally refers to the total amount of liraglutide contained in the injection pen. The actual daily dose should be selected and adjusted only according to a healthcare professional’s instructions.

A healthcare professional may assess:

• Treatment response
• Side effects
• Blood glucose results
• Digestive tolerance
• Current dose history
• Other medications
• Overall health condition

Patients should not increase, decrease, or stop the dose without medical advice.

How to Use Victoza® 18mg Injection

Use exactly as directed by your doctor, pharmacist, or healthcare provider.

General administration guidance may include:

• Inject under the skin as directed.
• Common injection areas may include the abdomen, thigh, or upper arm.
• Use according to the prescribed schedule.
• Do not inject into a vein or muscle.
• Rotate injection sites.
• Do not share injection pens or needles with others.
• Use a new needle for each injection.
• Follow your prescribed dosing schedule carefully.

Always follow the official prescription label, product instructions, and your healthcare provider’s guidance.

Who May Be Prescribed Victoza® 18mg Injection?

Victoza® 18mg Injection may be prescribed by a healthcare professional for suitable adult patients who need GLP-1 receptor agonist therapy as part of a medical treatment plan.

A doctor may assess:

• Medical history
• Blood sugar control
• Current treatment plan
• Previous response to GLP-1 therapy
• Digestive system condition
• Kidney and liver function
• Pregnancy or breastfeeding status
• Risk of drug interactions
• Risk of hypoglycemia when used with insulin or sulfonylureas
• Ability to use injectable medication safely

This medicine is not suitable for everyone.

Important Safety Information

Before using Victoza® 18mg Injection, tell your healthcare provider if you:

• Have a history of pancreatitis
• Have severe stomach or intestinal problems
• Have kidney disease
• Have liver disease
• Have diabetic retinopathy
• Are pregnant, planning pregnancy, or breastfeeding
• Are taking insulin or sulfonylurea medicines
• Have a history of thyroid tumors or endocrine disorders
• Have allergies to liraglutide or any ingredient in the injection
• Are taking other prescription or non-prescription medicines

Possible Side Effects

Common side effects may include:

• Nausea
• Vomiting
• Diarrhea
• Constipation
• Abdominal discomfort
• Loss of appetite
• Indigestion
• Bloating
• Fatigue
• Injection site reaction

Serious side effects may occur rarely and require medical attention.

Seek medical help immediately if you experience:

• Severe or persistent abdominal pain
• Severe vomiting or dehydration
• Signs of pancreatitis
• Allergic reaction
• Vision changes
• Symptoms of low blood sugar, especially when used with insulin or sulfonylurea
• Neck lump, difficulty swallowing, or persistent hoarseness
• Severe injection site reaction

Storage

Store according to the product package and pharmacist instructions.

General storage recommendations:

• Keep in original packaging.
• Store refrigerated before first use if required by product instructions.
• Do not freeze.
• Protect from heat and direct sunlight.
• Keep away from children and pets.
• Do not use after the expiry date.
• Dispose of used needles safely according to local guidance.

Important Notes

• Victoza® 18mg Injection is a prescription medicine.
• Use only under doctor supervision.
• Do not share this medicine, pen, or needles with others.
• Do not use for cosmetic weight loss without medical indication.
• Do not change dose without medical advice.
• It is not a substitute for diet, exercise, or diabetes care.
• Individual results and tolerability vary.

Disclaimer

This product page is for general product information only and does not replace professional medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.